Introduction to ARA-290 Peptide
ARA-290, also known as Cibinetide, is a synthetic peptide designed for research purposes to explore its potential benefits in tissue repair and pain relief. ARA-290 consists of 11 amino acids and is derived from the helix beta domain of erythropoietin (EPO).
Benefits of ARA-290 Peptide
ARA-290 is known for its ability to:
- Relieve neuropathic pain: Effective in alleviating pain associated with nerve damage, such as diabetic neuropathy and sarcoidosis-induced neuropathic pain.
- Promote tissue repair: Enhances tissue regeneration and repair, beneficial for recovery from injuries and surgeries.
- Boost immune function: Enhances the immune response, helping the body defend against infections and diseases more effectively.
- Fight diabetes: Plays a role in managing and potentially mitigating symptoms of diabetes by influencing glucose metabolism and insulin sensitivity.
- Support overall health: Offers multi-functional therapeutic potential for various conditions, making it a versatile addition to therapeutic regimens.
Certificate of Analysis
| Property | Description |
|---|---|
| Chemical Sequence | Ala-Glu-Asp-Leu |
| CAS | 158152-06-2 |
| Molecular Formula | C17H29N5O6 |
| Molecular Weight | Approximately 403.44 g/mol |
| Appearance | White Lyophilized Powder |
Research Use Only:
ARA-290 is intended strictly for in vitro testing and laboratory experimentation. It is not intended for human or animal medical use. It is not a drug, food, or cosmetic and should not be misbranded, misused, or mislabeled as such
Reviews
There are no reviews yet.